251 related articles for article (PubMed ID: 9155855)
1. Nebulised bronchodilators, corticosteroids, and rhDNase in adult patients with cystic fibrosis.
Conway SP; Watson A
Thorax; 1997 Apr; 52 Suppl 2(Suppl 2):S64-8. PubMed ID: 9155855
[No Abstract] [Full Text] [Related]
2. Nebulised bronchodilators, antibiotics and rhDNase for children with cystic fibrosis.
Spencer DA
Thorax; 1997 Apr; 52 Suppl 2(Suppl 2):S89-91. PubMed ID: 9155860
[No Abstract] [Full Text] [Related]
3. Where we are now with rhDNase.
Geddes DM; Shah PL
Lancet; 1999 May; 353(9166):1727. PubMed ID: 10347981
[No Abstract] [Full Text] [Related]
4. Consensus conference: practical applications of Pulmozyme. September 22, 1993.
Ramsey BW; Dorkin HL
Pediatr Pulmonol; 1994 Jun; 17(6):404-8. PubMed ID: 8090614
[No Abstract] [Full Text] [Related]
5. Aerosolized deoxyribonuclease for cystic fibrosis.
Med Lett Drugs Ther; 1994 Apr; 36(920):34-5. PubMed ID: 8145672
[No Abstract] [Full Text] [Related]
6. What is the cystic fibrosis clinician supposed to do with human recombinant dornase alfa?
Coates AL
J Pediatr; 2001 Dec; 139(6):768-70. PubMed ID: 11743499
[No Abstract] [Full Text] [Related]
7. Comparison of three jet nebulizer aerosol delivery systems used to administer recombinant human DNase I to patients with cystic fibrosis. The Pulmozyme rhDNase Study Group.
Fiel SB; Fuchs HJ; Johnson C; Gonda I; Clark AR
Chest; 1995 Jul; 108(1):153-6. PubMed ID: 7606951
[TBL] [Abstract][Full Text] [Related]
8. [New pharmacological approaches: rhDNase].
Tournier G; Sardet A; Grosskopf C; Baculard A; Delaisi B
Rev Pneumol Clin; 1995; 51(3):193-200. PubMed ID: 7569583
[TBL] [Abstract][Full Text] [Related]
9. [Inhaled bronchodilators and mucolytic agents in cystic fibrosis].
Le Roux P; Le Luyer B
Arch Pediatr; 2003 Sep; 10 Suppl 2():358s-363s. PubMed ID: 14671935
[TBL] [Abstract][Full Text] [Related]
10. Multicenter, open-label study of recombinant human DNase in cystic fibrosis patients with moderate lung disease. DNase International Study Group.
Harms HK; Matouk E; Tournier G; von der Hardt H; Weller PH; Romano L; Heijerman HG; FitzGerald MX; Richard D; Strandvik B; Kolbe J; Kraemer R; Michalsen H
Pediatr Pulmonol; 1998 Sep; 26(3):155-61. PubMed ID: 9773909
[TBL] [Abstract][Full Text] [Related]
11. Aerosolized recombinant human DNase I for the treatment of cystic fibrosis.
Shak S
Chest; 1995 Feb; 107(2 Suppl):65S-70S. PubMed ID: 7842816
[TBL] [Abstract][Full Text] [Related]
12. Use of computerized tomography and chest x-rays in evaluating efficacy of aerosolized recombinant human DNase in cystic fibrosis patients younger than age 5 years: a preliminary study.
Nasr SZ; Kuhns LR; Brown RW; Hurwitz ME; Sanders GM; Strouse PJ
Pediatr Pulmonol; 2001 May; 31(5):377-82. PubMed ID: 11340684
[TBL] [Abstract][Full Text] [Related]
13. [Perspective of use of rhDNase and new therapeutics for cystic fibrosis].
Navarro J; Munck A
Arch Pediatr; 1995 Jul; 2(7):682-4. PubMed ID: 7663661
[TBL] [Abstract][Full Text] [Related]
14. Statistical analysis of the long-term effects of recombinant human deoxyribonuclease on pulmonary function in cystic fibrosis patients.
Chen JJ; Hamilton SA
J Biopharm Stat; 2000 Aug; 10(3):287-97. PubMed ID: 10959912
[TBL] [Abstract][Full Text] [Related]
15. Effect of a short course of rhDNase on cough and mucociliary clearance in patients with cystic fibrosis.
Robinson M; Hemming AL; Moriarty C; Eberl S; Bye PT
Pediatr Pulmonol; 2000 Jul; 30(1):16-24. PubMed ID: 10862158
[TBL] [Abstract][Full Text] [Related]
16. rhDNase in cystic fibrosis.
Tyrrell JC; Lewis PA; Sheldon CD; Connett G
Thorax; 1999 Aug; 54(8):752. PubMed ID: 10490419
[No Abstract] [Full Text] [Related]
17. New treatment for cystic fibrosis.
Kuhn RJ
Am Pharm; 1994 Feb; NS34(2):16-8. PubMed ID: 8166040
[No Abstract] [Full Text] [Related]
18. Bronchoscopically administered recombinant human DNase for lobar atelectasis in cystic fibrosis.
Slattery DM; Waltz DA; Denham B; O'Mahony M; Greally P
Pediatr Pulmonol; 2001 May; 31(5):383-8. PubMed ID: 11340685
[TBL] [Abstract][Full Text] [Related]
19. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.
Fuchs HJ; Borowitz DS; Christiansen DH; Morris EM; Nash ML; Ramsey BW; Rosenstein BJ; Smith AL; Wohl ME
N Engl J Med; 1994 Sep; 331(10):637-42. PubMed ID: 7503821
[TBL] [Abstract][Full Text] [Related]
20. [Clinical development of rhDNase in the United States].
Eisenberg J
Arch Pediatr; 1995 Jul; 2(7):674-8. PubMed ID: 7663659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
